1 / 38

CVID and Good’s Syndrome: Causes of Hypogammaglobulinemia

CVID and Good’s Syndrome: Causes of Hypogammaglobulinemia. Pierre Yong, MD October 16, 2006. Causes of recurrent pulmonary infections. CVID Good’s syndrome Immotile cilia syndrome Cystic fibrosis Obstruction Leukocyte adhesion defects Neutropenia. CVID. Hypogammaglobulinemia

yule
Download Presentation

CVID and Good’s Syndrome: Causes of Hypogammaglobulinemia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CVID and Good’s Syndrome: Causes of Hypogammaglobulinemia Pierre Yong, MD October 16, 2006

  2. Causes of recurrent pulmonary infections • CVID • Good’s syndrome • Immotile cilia syndrome • Cystic fibrosis • Obstruction • Leukocyte adhesion defects • Neutropenia

  3. CVID • Hypogammaglobulinemia • Recurrent sinopulmonary infections • Poor B cell response to immunizations • Variable T cell defects

  4. Clinical manifestations • Infections • Sinopulmonary • Meningitis • Sepsis • Encapsulated organisms • Enterovirus

  5. Infections (con’td) Cunningham-Rundles C, Bodian C. 1999. CVID: clinical and immunological features of 248 patients. Clin Immunol. 92(1):34-48.

  6. Clinical manifestations (con’td) • Bronchiectasis • GI • Diarrhea • Giardiasis • Granulomatous disease • AI disease • AIHA • ITP

  7. Clinical manifestations (con’td) • Malignancy • Lymphoma • Gastric CA

  8. Pathogenesis • Unknown

  9. Monogenetic defects Salzer Ulrich et al. TACItly changing tunes: farewell to a yin and yang of BARR receptor and TACI in humoral immunity?: new genetic defects in CVID. 2005. Curr Opin Allergy Clin Immunol. 5(6):496-503.

  10. ICOS • Inducible co-stimulator of activated T cells • Expressed only on activated T cells • ICOS-ICOS ligand interaction is important for terminal B cell differentiation into memory cells and plasma cells • Homozygous deficiency (AR)

  11. ICOS in CVID Patients Grimbacker B et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. 2003. Nature Immunology. 4(3):261-68.

  12. TNF receptor superfamily http://www.medscape.com/viewarticle/516193_print

  13. TACI • Binds BAFF and APRIL • Impairment in T cell independent responses to polysaccharide antigens of encapuslated bacteria • Identified mutations in extracellular domain, transmembrane region and intracellular domain • AD and AR inheritance

  14. TACI and CSR Macpherson AJ et al. 2002. BlySsful interactions between DCs and B cells. Nature Immunology. 3(9):298-800.

  15. Thymus-dependent B cell activation Middleton’s Allergy. 6th Edition.

  16. CD19 • CD19 is part of the CD19 complex, which signals with BCR, decreasing the threshold for receptor-dependent signaling • Frameshift mutations cause premature stop codons, resulting in deletion of cytoplasmic domain of CD19 • Impaired calcium flux after stimulation of B cells van Zelm et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. NEJM. 2006. 354;18:1901-12.

  17. Work-up • Serum immunoglobulins • <2 SD below mean for age • Immunize • Pneumovax • Tetanus toxoid • Hib • Check pre- and post-immunization titers

  18. Treatment • IVIG • 400-500 mg/kg q4-5 wks • Antibiotics

  19. Thymomas • Neoplasm of thymic epithelial cells • Usually benign histology but can have aggressive behavior • Most common tumor of the anterior mediastinum • 90% of thymomas occur in mediastinum

  20. Signs and symptoms • Up to ½ of patients are asymptomatic • Can present with local or invasive organ involvement • Cough • Dypsnea • Chest pain • SVC syndrome • Hoarseness

  21. Signs and symptoms (con’td) • Can also present with associated paraneopolastic syndrome • Most clinically important syndromes are myasthenia gravis, pure red cell aplasia and hypogammaglobulinemia

  22. Paraneoplastic syndromes UpToDate. 2006. Clinical presentation and management of thymomas.

  23. Diagnosis • Imaging • CXR • CT • MRI • PET • Biopsy

  24. WHO Classification Reidel RF et al. 2006. Thymoma: benign appearance, malignant potential. Oncologist. 11:887-894.

  25. Good’s syndrome • Thymoma with associated hypogammaglobulinemia • Thymoma can precede or occur after develop of immunodeficiency Good RA. 1954. Agammaglobulinemia – a provocative experiment of nature. Bull Univ Minnesota. 26:1-19.

  26. Thymoma and Hypogammaglobulinemia

  27. Epidemiology • Occurs in less than 5% of thymomas • Usually older women • Usually spindle cell morphology • Occurs in up to 10% of patients presenting with hypogammaglobulinemia

  28. Signs and symptoms • Recurrent sinopulmonary infections with encapsulated organisms • Bacterial UTIs and skin infections • Arthritis • Opportunistic infections with viruses and fungi • Diarrhea (25-35%)

  29. Infections Tarr PE et al. 2001. Infections in patients with immunodeficiency with thymoma (Good Syndrome). Medicine. 80:123-133.

  30. Work-up • B cell defect • Few or absent B cells • Decreased quantitative immunoglobulins • T cell defect • Lymphopenia • CD4+ lymphopenia • Reversal of CD4:CD8 ratio • Impaired T cell response to mitogens Kellkher P et al. 2003. What is Good’s syndrome? Immunological abnormalities in patients with thymoma. J Clin Path. 56:12-16.

  31. Unusual case • 15 year old with thymoma and chronic thrush and generalized HSV-2 infections • Normal response to T cell mitogens • No response to Candida antigen at initial evaluation; but normal T cell proliferation 6 weeks after removal of thymoma • Anergy panel negative 1 week after removal of thymoma; + to Tetanus toxoid 5 weeks later Sicherer SH et al. 1998. Thymoma and cellular immune deficiency in an adolescent. Pediatr Allergy Immunol. 9:49-52.

  32. Unusual case (cont’d) • Normal serum Ig levels • Protective levels of antibody to Hib and a positive rubella titer • Normal response after booster doses of tetanus and diphtheria toxoids and immunization with pneumococcal vaccine

  33. Unclear pathogenesis • Cytokine secreted from bone marrow stromal cells • Autoantibodies • T cells directly or indirectly inhibit B cells

  34. Thymoma: Masoaka staging system Treatment Reidel RF et al. 2006. Thymoma: benign appearance, malignant potential. Oncologist. 11:887-894.

  35. Treatment (con’td) • Thymoma • Resection • Radiation • Chemotherapy • Hypogammaglobulinemia • IVIG • Tend not to improve after resection of thymoma

  36. CVID and Good’s Syndrome

  37. Summary • CVID is the second most common PID syndrome • Monogenetic defects have been identified a cause of CVID, but the pathogenesis in the majority of CVID patients is unknown • Good’s syndrome = thymoma + hypogammaglobulinemia

  38. Summary (con’td) • All patients with thymoma and any infections should be evaluated for possible hypogammaglobulinemia • Treatment for Good’s syndrome is Ig replacement and thymoma resection

More Related